CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Fastprinciple is developing a new drug candidate aimed at slowing the progression of Parkinson's disease, a major neurodegenerative disorder. This approach seeks to enhance the effectiveness of existing therapies rather than just alleviating symptoms, addressing a significant unmet medical need for millions of patients…
Patients and society expect that technical and scientific advances can provide novel improved answers to address unmet medical needs.
Parkinson's disease (PD) is the 2nd most prevalent neurodegenerative disorder in the world, with profound economic and social impacts.
The absence of preventive therapies to tackle PD, requires the development of new therapeutic strategies.
For Pharma companies, aiming to develop molecules for Parkinson Disease (PD) and other neurologic disorders, Fastprinciple is…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
